[Prevention of embolism in atrial septal defects?].
Franke
A
A
Medizinische Klinik I der Rheinisch-Westfälischen Technischen Hochschule, Aachen. afra@pcserver.mk1.rwth-aachen.de
D000328:Adult; D000367:Age Factors; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D003374:Coumarins / Q000008:administration & dosage / Q000627:therapeutic use; D004617:Embolism / Q000517:prevention & control*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006344:Heart Septal Defects, Atrial / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; C030123:coumarin; D001241:Aspirin